Neoadjuvant Pembrolizumab and Lenvatinib for Mucosal Melanoma

Clinical trial NCT05545969 · WITHDRAWN

Trial details

NCT number: NCT05545969
Sponsor: Melanoma Institute Australia
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

Mucosal Melanoma

Start date: 2024-03-01
Primary completion: 2026-05-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.